Whole Genome Data

BAM files and phenotype data available to all investigators through completion of a Data Access Procedures process in the St. Jude Cloud.

Public Access Whole Genome Data Tables

The table below provides characteristics for genome sequenced CCSS participants.

Characteristic	CCSS Participants with Whole Exome Data (N=2641)
Characteristic	N	%
Sex
Male	1240	47.5
Female	1401	52.5
Ancestry (based on genotype)
European	2114	78.8
Non-European	527	21.2
Primary Cancer Diagnosis
Acute lymphoblastic leumeia	452	35.1
Acute myeloid leukemia	77	2.3
Other leukemia	20	0.6
Astrocytoma	403	12.0
Medulloblastoma/PNET	167	5.0
Other CNS malignancy	104	3.1
Hodgkin lymphoma	311	9.2
Non-Hodgkin lymphoma	253	7.5
Kidney tumor	291	7.4
Neuroblastoma	256	7.6
Soft tissue sarcoma	138	4.1
Ewong sarcoma	90	2.7
Osteosarcoma	312	2.7
Other bone malignancy	20	0.6
Age at Cancer Diagnosis
0-4 yrs	922	39.9
5-9 yrs	626	25.9
10-14 yrs	654	20.8
15-21 yrs	439	13.4
Year of Cancer Diagnosis
1970 -1975	0
1976-1981	0
1982-1986	0
1987-1991	974	37.0
1992-1995	856	33.4
1996-1999	811	29.6
Radiotherapy for Primary Cancer
Yes	1011	33.2
No	1535	63.3
Unknown*	95	3.5
Chemotherapy for Primary Cancer
Yes	2057	82.0
No	490	14.5
Unknown*	94	3.5

Percentages weighted to reflect modified sampling of all survivors in expansion cohort; WES, Whole Exome Sequencing; WGS, Whole Genome Sequencing.

*Participants did not provide consent for medical record.
#WES Data, Original Cohort, is a subset of the population with genotype data.